Seroprevalence of Human Herpesvirus 8 Infection in Individuals From Health Care Centers in Mozambique: Potential for Endemic and Epidemic Kaposi`s Sarcoma


Autoria(s): CATERINO-DE-ARAUJO, Adele; MANUEL, Rolanda Carmen Rafael; BIANCO, Rosana Del; SANTOS-FORTUNA, Elizabeth; MAGRI, Mariana Cavalheiro; SILVA, Joyce Matie Kinoshita; BASTOS, Rui
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

20/10/2012

20/10/2012

2010

Resumo

Human herpesvirus 8 (HHV-8) infection is common in sub-Saharan Africa, but its prevalence in Mozambique is unknown. The seroprevalence of HHV-8 in a cohort of individuals seen at public health centers in Northern (n = 208), Central (n = 226), or Southern (n = 318) Mozambique was examined. All individuals were interviewed to obtain socioeconomic, demographic and clinical data and were tested for serum anti-HHV-8 antibodies using an immunofluorescence assay. The overall frequency of HHV-8 antibodies was 21.4% and, in spite of the diversity of epidemiological characteristics of the tested individuals, did not differ significantly among regions: 18.7%, 24.3% and 21.4% in the North, Center, and South, respectively (chi(2), 2.37; P = 0.305). The variables that were associated significantly with the presence of HHV-8 antibodies were gender, age, level of education, number of siblings and HIV serostatus, but these differed across the regions. In the North, although tested individuals lived under poor socioeconomic conditions, no association between HHV-8 infection and household variables was detected, with the exception of the number of siblings (P = 0.042). In the Central region, HHV-8 infection was associated with gender (P = 0.010), the number of household members (P = 0.031), and the place of attendance (P = 0.021). In the South, HHV-8 infection was associated with the number of siblings (P = 0.023) and HIV status (P = 0.002). The overall prevalence of HHV-8 seropositivity increased with age. These results demonstrate that Mozambique is another country in Africa with endemic HHV-8 infection, and, because of the AIDS epidemic, continued access to antiretroviral treatment is necessary to avert an outbreak of AIDS-Kaposi`s sarcoma. J. Med. Virol. 82:1216-1223, 2010. (C) 2010 Wiley-Liss, Inc.

Ministerio da Ciencia e Tecnologia/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (MCT/CNPq), Brasil[490452/2007-8]

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Ministerio da Ciencia e Tecnologia/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (MCT/CNPq), Brasil[304372/2006-4]

Instituto Adolfo Lutz (CTC)[55/06]

Instituto Adolfo Lutz

International Health Alliance (Mozambique)

International Health Alliance (Mozambique)

Identificador

JOURNAL OF MEDICAL VIROLOGY, v.82, n.7, p.1216-1223, 2010

0146-6615

http://producao.usp.br/handle/BDPI/28165

10.1002/jmv.21789

http://dx.doi.org/10.1002/jmv.21789

Idioma(s)

eng

Publicador

WILEY-LISS

Relação

Journal of Medical Virology

Direitos

restrictedAccess

Copyright WILEY-LISS

Palavras-Chave #epidemiology #human herpesvirus 8 (HHV-8) #HIV #risk factors #serology #AFRICAN PATIENTS #BLOOD-DONORS #CANCER #TUBERCULOSIS #POPULATION #THERAPY #BRAZIL #HHV-8 #RISK #Virology
Tipo

article

original article

publishedVersion